Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…
AI in Healthcare and Digital Health Today—October 27, 2025
This weekly roundup of AI in healthcare spans tools, care, and oversight,…
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…
Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051
Lucid Diligence Brief: ENA Respiratory Series B for intranasal INNA-051…
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies Professional…
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A Professional…
Lucid Diligence Brief: Electra Therapeutics $183M Series C
Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…
Lucid Diligence Brief: Takeda and Innovent global oncology partnership
Lucid Diligence Brief: Takeda and Innovent global oncology partnership…
Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics
Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics Professional…
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…